AA
NVO

Ancora Advisors’s Novo Nordisk NVO Stock Holding History

Ancora Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Buy
3,210
+829
+35% +$39.3K ﹤0.01% 866
2025
Q4 		$121K Sell
2,381
-556
-19% -$28.4K ﹤0.01% 872
2025
Q3 		$163K Sell
2,937
-250
-8% -$14.6K ﹤0.01% 763
2025
Q2 		$220K Sell
3,187
-50
-2% -$3.4K ﹤0.01% 700
2025
Q1 		$225K Buy
3,237
+425
+15% +$35.1K 0.01% 690
2024
Q4 		$242K Buy
2,812
+319
+13% +$34.5K 0.01% 671
2024
Q3 		$297K Buy
2,493
+325
+15% +$43.3K 0.01% 611
2024
Q2 		$309K Buy
2,168
+65
+3% +$8.61K 0.01% 587
2024
Q1 		$270K Buy
2,103
+181
+9% +$21.5K 0.01% 613
2023
Q4 		$199K Sell
1,922
-616
-24% -$60.9K ﹤0.01% 668
2023
Q3 		$231K Hold
2,538
– – 0.01% 633
2023
Q2 		$205K Hold
2,538
– – 0.01% 644
2023
Q1 		$202K Buy
2,538
+66
+3% +$4.68K 0.01% 640
2022
Q4 		$167K Hold
2,472
– – ﹤0.01% 713
2022
Q3 		$123K Buy
2,472
+100
+4% +$5.36K ﹤0.01% 844
2022
Q2 		$132K Sell
2,372
-164
-6% -$9.1K ﹤0.01% 875
2022
Q1 		$141K Hold
2,536
– – ﹤0.01% 916
2021
Q4 		$142K Hold
2,536
– – ﹤0.01% 918
2021
Q3 		$122K Hold
2,536
– – ﹤0.01% 916
2021
Q2 		$106K Sell
2,536
-888
-26% -$34.4K ﹤0.01% 893
2021
Q1 		$115K Buy
3,424
+1,524
+80% +$54.3K ﹤0.01% 842
2020
Q4 		$66K Sell
1,900
-1,528
-45% -$52.8K ﹤0.01% 825
2020
Q3 		$119K Buy
3,428
+464
+16% +$15.5K ﹤0.01% 690
2020
Q2 		$97K Sell
2,964
-60
-2% -$1.92K ﹤0.01% 720
2020
Q1 		$91K Hold
3,024
– – ﹤0.01% 796
2019
Q4 		$88K Buy
+3,024
New +$83.7K ﹤0.01% 801
2018
Q4 		– Sell
-4,024
Closed -$95K – 1008
2018
Q3 		$95K Buy
+4,024
New +$98.2K ﹤0.01% 764
2017
Q1 		– Sell
-9,500
Closed -$170K – 939
2016
Q4 		$170K Buy
+9,500
New +$172K 0.01% 578

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ancora Advisors's NVO Position: Q1 2026 in Review

Ancora Advisors increased its Novo Nordisk (NVO) stake by 35% in Q1 2026, buying an estimated $39.3K and bringing the position to 3,210 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Ancora Advisors first reported a position in NVO in Q4 2016 and has held it in 28 quarters since. The position peaked at $309K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Ancora Advisors held 3,210 shares of Novo Nordisk worth $118K as of Q1 2026.
  • Ancora Advisors bought 829 Novo Nordisk shares in Q1 2026, an estimated $39.3K.
  • Novo Nordisk made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #866 holding.
  • Ancora Advisors first reported a position in Novo Nordisk in Q4 2016 and has held it in 28 quarters since.
  • Ancora Advisors's Novo Nordisk position peaked at $309K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.